Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer's drug, lecanemab, in the EU after the European Commission on Friday asked the region's ...
Honda Motor Co. (NYSE:HMC) and Nissan Motor Co. (NSNAY) intend to unveil a detailed outline of their business integration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback